Evidence map›Paper›PMID 30908498›Full record

ArticlePloS one2019

Global DNA methylation of peripheral blood leukocytes from dogs bearing multicentric non-Hodgkin lymphomas and healthy dogs: A comparative study.

Tatiane Moreno Ferrarias Epiphanio, Natália Coelho Couto de Azevedo Fernandes, Tiago Franco de Oliveira, Priscila Assis Lopes, Rodrigo Albergaria Réssio, Simone Gonçalves, Náyra Villar Scattone, Marcello Vannucci Tedardi, Leslie Domenici Kulikowski, Jullian Damasceno and 2 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Epigenetic Mechanisms in Canine Cancer.Frontiers in oncology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Tatiane Moreno Ferrarias EpiphanioLaboratory of Experimental and Comparative Oncology, Department of Pathology, University of São Paulo, São Paulo, São Paulo, Brazil.
Natália Coelho Couto de Azevedo FernandesDepartment of Pathology, Adolfo Lutz Institute, São Paulo, São Paulo, Brazil.
Tiago Franco de OliveiraDepartment of Pharmacoscience, Federal University of Health Sciences of Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil.
Priscila Assis LopesVeterinary Laboratory, Veterinary Image Institute, IVI, São Paulo, São Paulo, Brazil.
Rodrigo Albergaria RéssioDepartment of Pathology, Adolfo Lutz Institute, São Paulo, São Paulo, Brazil.
Simone GonçalvesVeterinary Hemotherapy Center, Hemovet, São Paulo, São Paulo, Brazil.
Náyra Villar ScattoneLaboratory of Experimental and Comparative Oncology, Department of Pathology, University of São Paulo, São Paulo, São Paulo, Brazil.
Marcello Vannucci TedardiLaboratory of Experimental and Comparative Oncology, Department of Pathology, University of São Paulo, São Paulo, São Paulo, Brazil.
Leslie Domenici KulikowskiCytogenomic Laboratory, Department of Pathology, University of São Paulo, São Paulo, São Paulo, Brazil.
Jullian DamascenoCytogenomic Laboratory, Department of Pathology, University of São Paulo, São Paulo, São Paulo, Brazil.
Ana Paula de Melo LoureiroDepartment of Clinical and Toxicological Analysis, University of São Paulo, São Paulo, São Paulo, Brazil.
Maria Lucia Zaidan DagliLaboratory of Experimental and Comparative Oncology, Department of Pathology, University of São Paulo, São Paulo, São Paulo, Brazil.ORCID 0000-0001-7031-6711
Universidade de São Paulo · BRInstituto Adolfo Lutz · BRUniversidade Federal do Rio Grande do Sul · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-Hodgkin lymphomas are among the most common types of tumors in dogs, and they are currently accepted as comparative models of the disease in humans. Aberrant patterns of DNA methylation seem to play a key role in the development of hematopoietic neoplasms in humans, constitute a special mechanism of transcriptional control, and may be influenced by genetic and environmental factors. Blood leukocyte DNA global methylation has been poorly investigated in dogs. The aim of this study is to examine whether peripheral blood global DNA methylation is associated with canine multicentric lymphomas. Peripheral venous blood samples from ten healthy dogs and nine dogs bearing multicentric lymphomas were collected, and the buffy coat was separated. Global DNA methylation was analyzed by High Performance Liquid Chromatography (HPLC) and immunocytochemistry (ICC). In both analyses, leukocytes from dogs with lymphoma presented lower global DNA methylation than in healthy dogs (HPLC: p = 0.027/ 5MeCyt immunoreactivity scores: p = 0.015). Moderate correlation was observed between the results obtained by HPLC and ICC (correlation coefficient = 0.50). For the identification of differently methylated genes between both groups, the Infinium Human Methylation (HM) EPIC BeadChip (850K) was used. Of the 853,307 CpGs investigated in the microarray, there were 34,574 probes hybridized in the canine samples. From this total, significant difference was observed in the methylation level of 8433 regions, and through the homologous and orthologous similarities 525 differently methylated genes were identified between the two groups. This study is pioneer in suggesting that dogs bearing non-Hodgkin lymphoma presented DNA global hypomethylation of circulating leukocytes compared with healthy dogs. Although canine samples were used in an assay developed specifically for human DNA, it was possible to identify differently methylated genes and our results reiterate the importance of the use of peripheral blood leukocytes in cancer research and possible new biomarkers targets.

Indexed as

DNA MethylationLeukocytesAnimalsCase-Control StudiesCpG IslandsDog DiseasesDogsFemaleLymphoma, Non-HodgkinMale

Identifiers

PMID30908498
PMCPMC6433272
OpenAlexW2943656397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.